133 related articles for article (PubMed ID: 16025126)
1. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy.
Buitrago M; Lorenz K; Maass AH; Oberdorf-Maass S; Keller U; Schmitteckert EM; Ivashchenko Y; Lohse MJ; Engelhardt S
Nat Med; 2005 Aug; 11(8):837-44. PubMed ID: 16025126
[TBL] [Abstract][Full Text] [Related]
2. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
3. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes.
Bingham AJ; Ooi L; Kozera L; White E; Wood IC
Mol Cell Biol; 2007 Jun; 27(11):4082-92. PubMed ID: 17371849
[TBL] [Abstract][Full Text] [Related]
4. Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy.
McMullen JR; Izumo S
Novartis Found Symp; 2006; 274():90-111; discussion 111-7, 152-5, 272-6. PubMed ID: 17019808
[TBL] [Abstract][Full Text] [Related]
5. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
6. Multiple chromatin modifications important for gene expression changes in cardiac hypertrophy.
Bingham AJ; Ooi L; Wood IC
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1138-40. PubMed ID: 17073769
[TBL] [Abstract][Full Text] [Related]
7. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
8. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.
Xu J; Kimball TR; Lorenz JN; Brown DA; Bauskin AR; Klevitsky R; Hewett TE; Breit SN; Molkentin JD
Circ Res; 2006 Feb; 98(3):342-50. PubMed ID: 16397142
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction.
Weil J; Zolk O; Griepentrog J; Wenzel U; Zimmermann WH; Eschenhagen T
Cardiovasc Res; 2006 Feb; 69(2):412-22. PubMed ID: 16376326
[TBL] [Abstract][Full Text] [Related]
11. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
[TBL] [Abstract][Full Text] [Related]
12. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
Oka T; Maillet M; Watt AJ; Schwartz RJ; Aronow BJ; Duncan SA; Molkentin JD
Circ Res; 2006 Mar; 98(6):837-45. PubMed ID: 16514068
[TBL] [Abstract][Full Text] [Related]
13. Diurnal profiling of neuroendocrine genes in murine heart, and shift in proopiomelanocortin gene expression with pressure-overload cardiac hypertrophy.
Chalmers JA; Lin SY; Martino TA; Arab S; Liu P; Husain M; Sole MJ; Belsham DD
J Mol Endocrinol; 2008 Sep; 41(3):117-24. PubMed ID: 18550896
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiomyocyte polyploidy and multinucleation by CyclinG1.
Liu Z; Yue S; Chen X; Kubin T; Braun T
Circ Res; 2010 May; 106(9):1498-506. PubMed ID: 20360255
[TBL] [Abstract][Full Text] [Related]
15. NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes.
Kuratomi S; Kuratomi A; Kuwahara K; Ishii TM; Nakao K; Saito Y; Takano M
Biochem Biophys Res Commun; 2007 Feb; 353(1):67-73. PubMed ID: 17173866
[TBL] [Abstract][Full Text] [Related]
16. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.
Dai YS; Xu J; Molkentin JD
Mol Cell Biol; 2005 Nov; 25(22):9936-48. PubMed ID: 16260608
[TBL] [Abstract][Full Text] [Related]
17. Propranolol promotes Egr1 gene expression in cardiomyocytes via beta-adrenoceptors.
Patrizio M; Musumeci M; Stati T; Fecchi K; Mattei E; Catalano L; Marano G
Eur J Pharmacol; 2008 Jun; 587(1-3):85-9. PubMed ID: 18485346
[TBL] [Abstract][Full Text] [Related]
18. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
19. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy.
Sakamoto M; Minamino T; Toko H; Kayama Y; Zou Y; Sano M; Takaki E; Aoyagi T; Tojo K; Tajima N; Nakai A; Aburatani H; Komuro I
Circ Res; 2006 Dec; 99(12):1411-8. PubMed ID: 17095722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
